X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (938) 938
female (723) 723
leiomyosarcoma (701) 701
middle aged (531) 531
index medicus (517) 517
adult (439) 439
leiomyosarcoma - pathology (429) 429
aged (419) 419
male (417) 417
oncology (368) 368
tumors (328) 328
sarcoma (313) 313
pathology (310) 310
surgery (288) 288
prognosis (273) 273
uterine neoplasms - pathology (217) 217
immunohistochemistry (213) 213
cancer (203) 203
aged, 80 and over (185) 185
diagnosis (174) 174
retrospective studies (172) 172
leiomyosarcoma - surgery (171) 171
sarcoma - pathology (167) 167
leiomyosarcoma - diagnosis (161) 161
uterus (161) 161
diagnosis, differential (143) 143
leiomyoma (131) 131
chemotherapy (123) 123
medicine & public health (123) 123
leiomyoma - pathology (120) 120
obstetrics & gynecology (119) 119
treatment outcome (118) 118
survival (114) 114
metastasis (113) 113
analysis (102) 102
smooth-muscle tumors (101) 101
care and treatment (99) 99
adolescent (96) 96
neoplasm staging (94) 94
smooth muscle (94) 94
endometrial stromal sarcoma (93) 93
leiomyosarcoma - genetics (93) 93
prognostic-factors (93) 93
leiomyosarcomas (87) 87
sarcomas (86) 86
research (81) 81
biomarkers, tumor - analysis (80) 80
expression (80) 80
hysterectomy (80) 80
leiomyosarcoma - mortality (80) 80
leiomyosarcoma - metabolism (77) 77
follow-up studies (76) 76
survival rate (76) 76
uterine leiomyosarcoma (75) 75
uterine neoplasms - diagnosis (75) 75
management (72) 72
child (71) 71
uterine neoplasms - surgery (71) 71
leiomyosarcoma - classification (69) 69
uterine sarcoma (68) 68
sarcoma - diagnosis (66) 66
soft-tissue sarcomas (66) 66
soft tissue neoplasms - pathology (65) 65
gastrointestinal stromal tumors (63) 63
leiomyosarcoma - therapy (63) 63
medical prognosis (63) 63
neoplasms (63) 63
soft-tissue sarcoma (62) 62
classification (61) 61
liposarcoma (61) 61
obstetrics and gynecology (61) 61
disease-free survival (60) 60
survival analysis (60) 60
tomography, x-ray computed (59) 59
young adult (58) 58
mutation (57) 57
magnetic resonance imaging (56) 56
sarcoma - therapy (55) 55
biopsy (53) 53
health aspects (53) 53
soft tissue sarcoma (53) 53
cell biology (52) 52
radiotherapy (52) 52
leiomyomas (51) 51
patients (51) 51
differentiation (50) 50
radiology, nuclear medicine & medical imaging (50) 50
sarcoma - surgery (50) 50
animals (49) 49
case report (48) 48
gastrointestinal stromal tumors - pathology (48) 48
hematology, oncology and palliative medicine (48) 48
rhabdomyosarcoma (48) 48
leiomyosarcoma - secondary (47) 47
malignant fibrous histiocytoma (47) 47
uterine cancer (47) 47
endometrial cancer (46) 46
risk factors (46) 46
smooth muscle tumor - pathology (46) 46
carcinosarcoma (44) 44
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1149) 1149
French (29) 29
German (25) 25
Japanese (9) 9
Spanish (6) 6
Italian (5) 5
Russian (4) 4
Korean (3) 3
Chinese (2) 2
Czech (2) 2
Hebrew (1) 1
Latvian (1) 1
Persian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 12/2010, Volume 17, Issue 12, pp. 3220 - 3228
Unlike novel molecular-targeted therapies for metastatic gastrointestinal stromal tumors (GIST), conventional treatments for peritoneal sarcomatosis (PS) are... 
Oncology | Medicine & Public Health | Surgical Oncology | Surgery | SURGERY | GEMCITABINE PLUS DOCETAXEL | ONCOLOGY-GROUP | UTERINE LEIOMYOSARCOMA | PROGNOSTIC-FACTORS | ONCOLOGY | RETROPERITONEAL LIPOSARCOMA | DISSEMINATED ABDOMINAL SARCOMA | CARCINOMATOSIS | GROUP PHASE-II | SURGICAL RESECTION | GASTROINTESTINAL STROMAL TUMORS | Uterine Neoplasms - therapy | Prospective Studies | Uterine Neoplasms - pathology | Humans | Middle Aged | Retroperitoneal Neoplasms - therapy | Male | Liposarcoma - classification | Leiomyosarcoma - classification | Cisplatin - administration & dosage | Young Adult | Hyperthermia, Induced | Adult | Female | Peritoneal Neoplasms - classification | Retroperitoneal Neoplasms - pathology | Uterine Neoplasms - classification | Doxorubicin - administration & dosage | Peritoneal Neoplasms - pathology | Retroperitoneal Neoplasms - classification | Leiomyosarcoma - pathology | Liposarcoma - pathology | Survival Rate | Treatment Outcome | Combined Modality Therapy | Leiomyosarcoma - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Liposarcoma - therapy | Aged | Neoplasm Staging | Mitomycin - administration & dosage | Peritoneal Neoplasms - therapy | Chemotherapy, Cancer, Regional Perfusion | Anthracyclines | Chemotherapy | Sarcoma | Analysis | Development and progression | Metastasis | Health aspects | Cancer
Journal Article
Histopathology, ISSN 0309-0167, 04/2015, Volume 66, Issue 5, pp. 627 - 638
Aims Well‐differentiated leiomyosarcomas show morphologically recognizable smooth muscle differentiation, whereas poorly differentiated tumours may form a... 
leiomyosarcoma | desmin | differentiation | immunohistochemistry | prognosis | Immunohistochemistry | Prognosis | Differentiation | Desmin | Leiomyosarcoma | SOFT-TISSUE SARCOMAS | MANAGEMENT | MARKERS |